1. Home
  2. NTRA vs JBL Comparison

NTRA vs JBL Comparison

Compare NTRA & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.88

Market Cap

29.2B

Sector

Health Care

ML Signal

HOLD

Logo Jabil Inc.

JBL

Jabil Inc.

HOLD

Current Price

$353.74

Market Cap

27.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
JBL
Founded
2003
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
27.0B
IPO Year
2015
1998

Fundamental Metrics

Financial Performance
Metric
NTRA
JBL
Price
$197.88
$353.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
9
Target Price
$259.07
$272.33
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
05-07-2026
06-16-2026
Dividend Yield
N/A
0.10%
EPS Growth
0.65
N/A
EPS
N/A
3.43
Revenue
$210,939,000.00
$25,282,320,000.00
Revenue This Year
$18.08
$15.81
Revenue Next Year
$19.65
$9.76
P/E Ratio
N/A
$103.71
Revenue Growth
N/A
14.42
52 Week Low
$131.81
$161.52
52 Week High
$256.36
$372.37

Technical Indicators

Market Signals
Indicator
NTRA
JBL
Relative Strength Index (RSI) 46.96 60.99
Support Level $187.27 $201.06
Resistance Level $204.34 $372.37
Average True Range (ATR) 10.36 13.59
MACD -1.12 -1.23
Stochastic Oscillator 28.02 60.94

Price Performance

Historical Comparison
NTRA
JBL

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About JBL Jabil Inc.

Jabil Inc. is a U.S based company providing engineering, manufacturing, and supply chain solutions. It provides comprehensive electronics design, production, and product management services to companies in various industries and end markets. It operates through three segments: Regulated Industries, serving automotive, healthcare, and renewables; Intelligent Infrastructure, focused on AI, cloud, data centers, and communications, driving the majority of revenue; and Connected Living and Digital Commerce, specializing in digitalization and automation, such as robotics and warehouse automation. The company operates in the U.S., Mexico, China, Malaysia, Singapore, and several other markets.

Share on Social Networks: